- Type / Class
- Equity / Common Stock
- Shares outstanding
- 61,152,075
- Total 13F shares
- 60,687,245
- Share change
- -156,412
- Total reported value
- $8,276,478,215
- Put/Call ratio
- 183%
- Price per share
- $136.38
- Number of holders
- 202
- Value change
- -$25,623,552
- Number of buys
- 111
- Number of sells
- 89
Quarterly Holders Quick Answers
What is CUSIP 04351P101?
CUSIP 04351P101 identifies ASND - Ascendis Pharma A/S - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04351P101:
Top shareholders of ASND - Ascendis Pharma A/S - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
17%
|
10,108,400
|
$1,528,086,828 | — | 31 Mar 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
9.3%
|
5,671,934
|
$857,426,263 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
8.1%
|
4,938,461
|
$746,547,150 | — | 31 Mar 2024 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
6.7%
|
4,075,214
|
$616,050,091 | — | 31 Mar 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
6.5%
|
3,966,666
|
$599,640,899 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
6.2%
|
3,767,203
|
$569,378,169 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
4.5%
|
2,745,872
|
$415,093,470 | — | 31 Mar 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
4.2%
|
2,568,903
|
$388,342,000 | — | 31 Mar 2024 | |
| Capital International Investors |
13F
|
Company |
3.6%
|
2,191,312
|
$331,260,635 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3.2%
|
1,981,869
|
$299,599,191 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.9%
|
1,781,926
|
$269,374,000 | — | 31 Mar 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
2.6%
|
1,617,830
|
$244,567,361 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.6%
|
964,663
|
$145,828,106 | — | 31 Mar 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
1.2%
|
754,032
|
$113,987,017 | — | 31 Mar 2024 | |
| BROWN ADVISORY INC |
13F
|
Company |
1.1%
|
684,072
|
$103,411,179 | — | 31 Mar 2024 | |
| Spyglass Capital Management LLC |
13F
|
Company |
1%
|
614,107
|
$92,834,555 | — | 31 Mar 2024 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.94%
|
575,698
|
$87,028,000 | — | 31 Mar 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.86%
|
525,000
|
$79,364,250 | — | 31 Mar 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
0.83%
|
507,952
|
$76,787,104 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.77%
|
473,753
|
$71,617,241 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.75%
|
457,504
|
$69,160,880 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.71%
|
437,092
|
$66,075,198 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.66%
|
405,169
|
$61,249,398 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.59%
|
362,060
|
$54,732,610 | — | 31 Mar 2024 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.57%
|
346,186
|
$52,332,937 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.56%
|
340,118
|
$51,415,638 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.5%
|
307,499
|
$46,484,624 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.5%
|
306,141
|
$46,279,432 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.47%
|
290,000
|
$43,839,300 | — | 31 Mar 2024 | |
| Q Global Advisors, LLC |
13F
|
Company |
0.47%
|
285,000
|
$43,083,000 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.44%
|
270,770
|
$40,932,301 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.43%
|
264,445
|
$39,976,151 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.43%
|
261,029
|
$39,459,754 | — | 31 Mar 2024 | |
| ARS Investment Partners, LLC |
13F
|
Company |
0.42%
|
254,967
|
$38,543,361 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.41%
|
250,492
|
$37,849,000 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.39%
|
236,870
|
$35,807,638 | — | 31 Mar 2024 | |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
225,111
|
$34,030,030 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.34%
|
210,325
|
$31,794,830 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.34%
|
209,512
|
$31,671,929 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.32%
|
196,079
|
$29,641,262 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.32%
|
196,030
|
$29,633,855 | — | 31 Mar 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.31%
|
189,208
|
$28,602,541 | — | 31 Mar 2024 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
186,121
|
$28,135,912 | — | 31 Mar 2024 | |
| Finepoint Capital LP |
13F
|
Company |
0.29%
|
175,672
|
$26,556,336 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.27%
|
163,400
|
$24,701,178 | — | 31 Mar 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.27%
|
162,412
|
$24,551,822 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.25%
|
152,052
|
$22,985,814 | — | 31 Mar 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.25%
|
151,587
|
$22,915,407 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.25%
|
150,944
|
$22,818,264 | — | 31 Mar 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.23%
|
138,791
|
$20,981,035 | — | 31 Mar 2024 |
Institutional Holders of Ascendis Pharma A/S - Common Stock (ASND) as of Q2 2024
As of 30 Jun 2024,
Ascendis Pharma A/S - Common Stock (ASND) was held by
202 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,687,245 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., WESTFIELD CAPITAL MANAGEMENT CO LP, FMR LLC, Artisan Partners Limited Partnership, Avoro Capital Advisors LLC, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, Capital International Investors, FRANKLIN RESOURCES INC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
203
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
188
Q2 2024 holders
202
Holder diff
14
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.